The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ADC THERAPEUTICS SA | SHS | H0036K147 | 1,682,476 | 1,013,540 | SH | SOLE | 1,013,540 | 0 | 0 | ||
ALKERMES PLC | SHS | G01767105 | 9,886,092 | 356,384 | SH | SOLE | 356,384 | 0 | 0 | ||
ALKERMES PLC | SHS | G01767105 | 748,980 | 27,000 | SH | Put | SOLE | 27,000 | 0 | 0 | |
ALLOGENE THERAPEUTICS INC | COM | 019770106 | 1,284,000 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 5,742,300 | 30,000 | SH | Call | SOLE | 30,000 | 0 | 0 | |
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 4,489,500 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 1,496,500 | 25,000 | SH | Call | SOLE | 25,000 | 0 | 0 | |
APOGEE THERAPEUTICS INC | COM | 03770N101 | 15,006,378 | 537,093 | SH | SOLE | 537,093 | 0 | 0 | ||
ARAVIVE INC | COM | 03890D108 | 42,863 | 346,511 | SH | SOLE | 346,511 | 0 | 0 | ||
ARCELLX INC | COMMON STOCK | 03940C100 | 18,870,000 | 340,000 | SH | SOLE | 340,000 | 0 | 0 | ||
ARGENX SE | SPONSORED ADR | 04016X101 | 2,853,225 | 7,500 | SH | SOLE | 7,500 | 0 | 0 | ||
ASCENDIS PHARMA A/S | SPONSORED ADR | 04351P101 | 2,519,000 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
ASTRAZENECA PLC | SPONSORED ADR | 046353108 | 4,041,000 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | ||
ASTRIA THERAPEUTICS INC | COM | 04635X102 | 11,262,451 | 1,466,465 | SH | SOLE | 1,466,465 | 0 | 0 | ||
AUTOLUS THERAPEUTICS PLC | SPON ADS | 05280R100 | 9,984,628 | 1,550,408 | SH | SOLE | 1,550,408 | 0 | 0 | ||
AVROBIO INC | COM | 05455M100 | 680,000 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
AXSOME THERAPEUTICS INC | COM | 05464T104 | 3,979,500 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
BIOHAVEN LTD | COM | G1110E107 | 893,065 | 20,866 | SH | SOLE | 20,866 | 0 | 0 | ||
BRIDGEBIO PHARMA INC | NOTE 2.500% 3/1 | 10806XAB8 | 20,578,500 | 17,000,000 | PRN | SOLE | 17,000,000 | 0 | 0 | ||
BRIDGEBIO PHARMA INC | COM | 10806X102 | 3,229,600 | 80,000 | SH | SOLE | 80,000 | 0 | 0 | ||
CASSAVA SCIENCES INC | COM | 14817C107 | 2,723,710 | 121,000 | SH | Call | SOLE | 121,000 | 0 | 0 | |
CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | 15,864,000 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
CENTESSA PHARMACEUTICALS PLC | SPONSORED ADS | 152309100 | 6,334,003 | 795,729 | SH | SOLE | 795,729 | 0 | 0 | ||
CEREVEL THERAPEUTICS HLDNG I | COM | 15678U128 | 31,800,000 | 750,000 | SH | SOLE | 750,000 | 0 | 0 | ||
COHERUS BIOSCIENCES INC | NOTE 1.500% 4/1 | 19249HAB9 | 3,403,157 | 6,000,000 | PRN | SOLE | 6,000,000 | 0 | 0 | ||
COMPASS PATHWAYS PLC | SPONSORED ADS | 20451W101 | 4,812,500 | 550,000 | SH | SOLE | 550,000 | 0 | 0 | ||
CONTEXT THERAPEUTICS INC | COM | 21077P108 | 371,563 | 328,817 | SH | SOLE | 328,817 | 0 | 0 | ||
CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | 15,907,640 | 447,095 | SH | SOLE | 447,095 | 0 | 0 | ||
CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | 3,355,194 | 94,300 | SH | Put | SOLE | 94,300 | 0 | 0 | |
CULLINAN ONCOLOGY INC | COM | 230031106 | 3,057,000 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
CYMABAY THERAPEUTICS INC | COM | 23257D103 | 25,756,216 | 1,090,441 | SH | SOLE | 1,090,441 | 0 | 0 | ||
CYTOKINETICS INC | COM NEW | 23282W605 | 13,358,400 | 160,000 | SH | SOLE | 160,000 | 0 | 0 | ||
DYNAVAX TECHNOLOGIES CORP | COM NEW | 268158201 | 4,194,000 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
ESTABLISHMENT LABS HLDGS INC | COM | G31249108 | 5,910,092 | 228,277 | SH | SOLE | 228,277 | 0 | 0 | ||
ESTABLISHMENT LABS HLDGS INC | COM | G31249108 | 5,825,250 | 225,000 | SH | Call | SOLE | 225,000 | 0 | 0 | |
EYEPOINT PHARMACEUTICALS INC | COM NEW | 30233G209 | 7,397,511 | 320,100 | SH | Put | SOLE | 320,100 | 0 | 0 | |
EYEPOINT PHARMACEUTICALS INC | COM NEW | 30233G209 | 2,539,789 | 109,900 | SH | SOLE | 109,900 | 0 | 0 | ||
FULCRUM THERAPEUTICS INC | COM | 359616109 | 843,750 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
IMMATICS N.V | SHS | N44445109 | 2,106,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
IMMATICS N.V | W EXP 07/01/202 | N44445117 | 546,636 | 187,204 | SH | SOLE | 187,204 | 0 | 0 | ||
IMMUNOGEN INC | COM | 45253H101 | 41,646,627 | 1,404,608 | SH | SOLE | 1,404,608 | 0 | 0 | ||
IMMUNOVANT INC | COM | 45258J102 | 14,534,850 | 345,000 | SH | SOLE | 345,000 | 0 | 0 | ||
INARI MED INC | COM | 45332Y109 | 1,298,400 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
INFLARX NV | COM | N44821101 | 326,158 | 200,097 | SH | SOLE | 200,097 | 0 | 0 | ||
INOZYME PHARMA INC | COM | 45790W108 | 8,033,517 | 1,885,802 | SH | SOLE | 1,885,802 | 0 | 0 | ||
KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 1,543,120 | 125,969 | SH | SOLE | 125,969 | 0 | 0 | ||
KRYSTAL BIOTECH INC | COM | 501147102 | 3,101,500 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | ||
KURA ONCOLOGY INC | COM | 50127T109 | 2,754,273 | 191,535 | SH | SOLE | 191,535 | 0 | 0 | ||
LIANBIO | SPONSORED ADS | 53000N108 | 16,895,232 | 3,779,694 | SH | SOLE | 3,779,694 | 0 | 0 | ||
MADRIGAL PHARMACEUTICALS INC | COM | 558868105 | 23,138,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
MERSANA THERAPEUTICS INC | COM | 59045L106 | 2,320,000 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
MIRATI THERAPEUTICS INC | COM | 60468T105 | 5,877,879 | 100,049 | SH | SOLE | 100,049 | 0 | 0 | ||
MIRUM PHARMACEUTICALS INC | COM | 604749101 | 1,476,000 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
MOONLAKE IMMUNOTHERAPEUTICS | CLASS A ORD | 61559X104 | 4,286,965 | 70,988 | SH | SOLE | 70,988 | 0 | 0 | ||
MORPHIC HLDG INC | COM | 61775R105 | 1,232,310 | 42,670 | SH | SOLE | 42,670 | 0 | 0 | ||
NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 1,317,600 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
NEWAMSTERDAM PHARMA COMPANY | ORDINARY SHARES | N62509109 | 1,396,250 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
NEWAMSTERDAM PHARMA COMPANY | W EXP 11/22/202 | N62509117 | 428,810 | 137,000 | SH | SOLE | 137,000 | 0 | 0 | ||
NURIX THERAPEUTICS INC | COM | 67080M103 | 7,121,956 | 690,112 | SH | SOLE | 690,112 | 0 | 0 | ||
NUVALENT INC | COM | 670703107 | 12,878,250 | 175,000 | SH | SOLE | 175,000 | 0 | 0 | ||
NUVATION BIO INC | COM CL A | 67080N101 | 377,500 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
OMEROS CORP | NOTE 5.250% 2/1 | 682143AG7 | 3,600,000 | 6,000,000 | PRN | SOLE | 6,000,000 | 0 | 0 | ||
PENUMBRA INC | COM | 70975L107 | 1,886,550 | 7,500 | SH | SOLE | 7,500 | 0 | 0 | ||
PROMIS NEUROSCIENCES INC | COM NEW | 74346M406 | 305,852 | 265,958 | SH | SOLE | 265,958 | 0 | 0 | ||
PUMA BIOTECHNOLOGY INC | COM | 74587V107 | 876,171 | 202,349 | SH | SOLE | 202,349 | 0 | 0 | ||
RELAY THERAPEUTICS INC | COM | 75943R102 | 3,303,000 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
ROCKET PHARMACEUTICALS INC | W EXP 09/02/202 | 77313F114 | 36,750 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
ROIVANT SCIENCES LTD | SHS | G76279101 | 5,615,000 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
SAVARA INC | COM | 805111101 | 5,405,000 | 1,150,000 | SH | SOLE | 1,150,000 | 0 | 0 | ||
SPRINGWORKS THERAPEUTICS INC | COM | 85205L107 | 3,650,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
SPYRE THERAPEUTICS INC | COM NEW | 00773J202 | 11,137,762 | 517,554 | SH | SOLE | 517,554 | 0 | 0 | ||
STRUCTURE THERAPEUTICS INC | SPONSORED ADS | 86366E106 | 4,076,000 | 100,000 | SH | Call | SOLE | 100,000 | 0 | 0 | |
TOURMALINE BIO INC | COM | 89157D105 | 1,782,361 | 68,081 | SH | SOLE | 68,081 | 0 | 0 | ||
TANGO THERAPEUTICS INC | COM | 87583X109 | 2,972,713 | 300,274 | SH | SOLE | 300,274 | 0 | 0 | ||
TERNS PHARMACEUTICALS INC | COM | 880881107 | 428,340 | 66,000 | SH | SOLE | 66,000 | 0 | 0 | ||
TEVA PHARMACEUTICAL INDS LTD | SPONSORED ADS | 881624209 | 19,836,000 | 1,900,000 | SH | SOLE | 1,900,000 | 0 | 0 | ||
TEVA PHARMACEUTICAL INDS LTD | SPONSORED ADS | 881624209 | 14,616,000 | 1,400,000 | SH | Call | SOLE | 1,400,000 | 0 | 0 | |
VAXCYTE INC | COM | 92243G108 | 1,570,000 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | ||
VERONA PHARMA PLC | SPONSORED ADS | 925050106 | 11,208,821 | 563,824 | SH | SOLE | 563,824 | 0 | 0 | ||
VIKING THERAPEUTICS INC | COM | 92686J106 | 5,583,000 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 1,089,000 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
XENON PHARMACEUTICALS INC | COM | 98420N105 | 21,187,600 | 460,000 | SH | SOLE | 460,000 | 0 | 0 |